Bryan Smith - Feb 1, 2022 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
General Counsel, Corporate Sec
Signature
/s/ Bryan E. Smith
Stock symbol
ELDN
Transactions as of
Feb 1, 2022
Transactions value $
$0
Form type
4
Date filed
2/2/2022, 04:37 PM
Next filing
Feb 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELDN Stock Option (right to buy) Award $0 +120K $0.00 120K Feb 1, 2022 Common Stock 120K $3.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase up to 120,000 shares of Common Stock, which option vests with respect to 30,000 shares on February 1, 2023, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending February 1, 2026.